Q1 Snapshot: Device Recalls Fell Over Past Two Quarters; Troubles With Quality, Labeling Top List Of Recall Causes
This article was originally published in The Gray Sheet
Executive Summary
The number of device recalls dropped over the past six months, but the downward trajectory likely will not hold through the remainder of 2016, an industry expert says. Meanwhile, mislabeling and quality problems caused the most headaches for manufacturers in the first quarter of 2016, registering as the top two causes for a recall.
You may also be interested in...
Q2 Snapshot: Device Recalls On Upswing; Software, Mislabeling Top List Of Recall Causes
The number of device recalls crept up over the past three months, and the upward trajectory will likely continue through the remainder of 2016, an industry expert says. Software and mislabeling caused the most headaches for manufacturers in the second quarter of 2016, registering as the top two reasons for a recall.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.